Enhancement by cyclo‐oxygenase inhibitors of platelet‐activating factor production in thapsigargin‐stimulated macrophages
Open Access
- 1 October 1995
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 116 (3) , 2141-2147
- https://doi.org/10.1111/j.1476-5381.1995.tb16423.x
Abstract
1 Thapsigargin stimulated the accumulation of cell-associated platelet-activating factor (PAF) and extracellular prostaglandin E2 (PGE2) in rat peritoneal macrophages. PAF in the conditioned medium was less than the detectable amount. To obtain further insight into the mechanism of PAF accumulation, the role of PGE2 in PAF accumulation was investigated. 2 When macrophages were incubated in medium containing thapsigargin (30 ng ml−1, 46.1 nM) and cyclo-oxygenase inhibitors such as indomethacin, naproxen or ibuprofen, the PAF content of the cells at 10 min was increased in a concentration-dependent manner in accordance with inhibition of PGE2 production. The stimulation of PAF accumulation by cyclo-oxygenase inhibitors was significant at 10 min. Without stimulation by thapsigargin, cyclo-oxygenase inhibitors did not increase PAF accumulation. 3 In thapsigargin-stimulated macrophages, when PGE2 (10−7 m) was added to the medium, the cyclo-oxygenase inhibitor-induced stimulation of PAF accumulation at 10 min was markedly inhibited. 4 The accumulation of PAF induced by thapsigargin alone at 10 min was also inhibited by exogenous PGE2 (10−8 and 10−7 m), or arachidonic acid (10−6 and 10−5 m) in accordance with the increase in PGE2 production. 5 The accumulation of PAF induced by thapsigargin alone or by thapsigargin and indomethacin (10−6M) was inhibited by dibutyryl cyclic AMP. 6 These results indicate that the concurrently produced PGE2 in thapsigargin-stimulated macrophages down-regulates PAF accumulation by increasing intracellular cyclic AMP levels, and that cyclo-oxygenase inhibitors increase PAF accumulation by inhibiting PGE2 production.Keywords
This publication has 49 references indexed in Scilit:
- The calcium mobilizing and tumor promoting agent, thapsigargin elevates the platelet cytoplasmic free calcium concentration to a higher steady state level. A possible mechanism of action for the tumor promotionBiochemical and Biophysical Research Communications, 1987
- Synergistic stimulation of histamine release from rat peritoneal mast cells by 12-O-tetradecanoylphorbol 13-acetate (TPA)-type and non-TPA-type tumor promotersBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1986
- Stimulation of prostaglandin E2 production by 12-O-tetradecanoylphorbol 13-acetate (TPA)-type and non-TPA-type tumor promoters in macrophages and its inhibition by cycloheximideBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1985
- Lipid-mediator synthesis in peritoneal macrophages from mice injected with immunostimulantsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983
- Thapsigargin and thapsigargicin, two histamine liberating sesquiterpene lactones from Thapsia garganica. X-ray analysis of the 7,11-epoxide of thapsigarginThe Journal of Organic Chemistry, 1982
- Activation of Rabbit Platelets by Platelet-Activating Factor Derived from IgE-Sensitized BasophilsJournal of Clinical Investigation, 1977
- Activation of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. II. The role of serine proteases, cyclic nucleotides, and contractile elements in PAF-induced secretion.The Journal of Experimental Medicine, 1976
- Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophilsNature, 1974
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959